Abstract
Blepharospasm (BSP) is a neurological movement disorder. Coffee consumption has been found to have a protective effect against BSP. BSP and apraxia of eyelid opening are particularly common among patients with PD. The CYP1A2 rs762551 and ADORA2A rs5760423 variants have been previously marginally associated with the risk of PD and are also implicated in caffeine metabolism pathways. The aim of the present study was to evaluate the effect of the CYP1A2 rs762551 and ADORA2A rs5760423 variants on BSP. A Southeastern European Caucasian (SEC) cohort of 206 BSP patients and 206 healthy controls was genotyped for rs762551 and rs5760423. CYP1A2 rs762551 was associated with a decreased BSP risk in the dominant (OR (95% CI) 0.62 (0.41–0.92), p = 0.017), log-additive (OR (95% CI) 0.68 (0.51–0.92), p = 0.011), and co-dominant modes (for the CC genotype OR (95% CI) 0.49 (0.25–0.93), p = 0.038). We provide preliminary evidence that CYP1A2 rs762551 is associated with BSP. Further studies and replication of our results are needed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albanese A et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863–873. https://doi.org/10.1002/mds.25475
Albanese A, Di Giovanni M, Lalli S (2019) Dystonia: diagnosis and management. Eur J Neurol 26:5–17. https://doi.org/10.1111/ene.13762
Aloizou AM et al (2020) Pesticides, cognitive functions and dementia: a review. Toxicol Lett 326:31–51. https://doi.org/10.1016/j.toxlet.2020.03.005
Chen JF et al (2001) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson’s disease. J Neurosci 21:Rc143
Chuang YH et al (2016) Gene-environment interaction in Parkinson’s disease: coffee, ADORA2A, and CYP1A2. Neuroepidemiology 47:192–200. https://doi.org/10.1159/000450855
Dardiotis E et al (2015) Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury. Pharmacogenet Genomics 25:485–490. https://doi.org/10.1097/fpc.0000000000000161
Dardiotis E et al (2017) Integrins AV and B8 gene polymorphisms and risk for intracerebral hemorrhage in Greek and Polish populations. Neuromolecular Med 19:69–80. https://doi.org/10.1007/s12017-016-8429-3
Dardiotis E et al (2018) Genetic polymorphisms in amyotrophic lateral sclerosis: evidence for implication in detoxification pathways of environmental toxicants. Environ Int 116:122–135. https://doi.org/10.1016/j.envint.2018.04.008
Defazio G et al (2007) Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control study. J Neurol Neurosurg Psychiatry 78:877–879. https://doi.org/10.1136/jnnp.2007.119891
Defazio G, Hallett M, Jinnah HA, Berardelli A (2013) Development and validation of a clinical guideline for diagnosing blepharospasm. Neurology 81:236–240. https://doi.org/10.1212/WNL.0b013e31829bfdf6
Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A (2017) Blepharospasm 40 years later. Mov Disord 32:498–509. https://doi.org/10.1002/mds.26934
Defazio G et al (2019) Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia. Neurol Sci 40:89–95. https://doi.org/10.1007/s10072-018-3586-9
Docea AO et al (2017) CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep 4:335–341. https://doi.org/10.1016/j.toxrep.2017.05.007
Dong H, Luo Y, Fan S, Yin B, Weng C, Peng B (2019) Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm. Front Neurol 10:1387. https://doi.org/10.3389/fneur.2019.01387
Groen JL et al (2012) Association of BDNF Met66Met polymorphism with arm tremor in cervical dystonia. Mov Disord 27:796–797. https://doi.org/10.1002/mds.24922
Gunes A, Dahl ML (2008) Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 9:625–637. https://doi.org/10.2217/14622416.9.5.625
Hallett M, Evinger C, Jankovic J, Stacy M (2008) Update on blepharospasm: report from the BEBRF International Workshop. Neurology 71:1275–1282. https://doi.org/10.1212/01.wnl.0000327601.46315.85
Hammer M, Abravanel A, Peckham E, Mahloogi A, Majounie E, Hallett M, Singleton A (2019) Blepharospasm: a genetic screening study in 132 patients. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2019.04.003
Horgusluoglu-Moloch E et al (2017) Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 60:92–103. https://doi.org/10.1016/j.neurobiolaging.2017.08.010
Jellinger KA (2019) Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders. J Neural Transm (Vienna) 126:997–1027. https://doi.org/10.1007/s00702-019-02030-y
Jinnah HA, Neychev V, Hess EJ (2017) The anatomical basis for dystonia: the motor network model. Tremor Other Hyperkinet Mov (N Y) 7:506. https://doi.org/10.7916/d8v69x3s
Koonrungsesomboon N, Khatsri R, Wongchompoo P, Teekachunhatean S (2018) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharm J 18:760–768. https://doi.org/10.1038/s41397-017-0011-3
Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel’s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 39:1204–1209
Nery TGM, Silva EM, Tavares R, Passetti F (2019) The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach. J Mol Neurosci 67:150–164. https://doi.org/10.1007/s12031-018-1220-1
Ohlei O, Dobricic V, Lohmann K, Klein C, Lill CM, Bertram L (2018) Field synopsis and systematic meta-analyses of genetic association studies in isolated dystonia. Parkinsonism Relat Disord 57:50–57. https://doi.org/10.1016/j.parkreldis.2018.07.018
Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A (2010) Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson’s disease in men and women. Parkinsonism Relat Disord 16:370–375. https://doi.org/10.1016/j.parkreldis.2010.02.012
Pirio Richardson S, Jinnah HA (2019) New approaches to discovering drugs that treat dystonia. Expert Opin Drug Discov 14:893–900. https://doi.org/10.1080/17460441.2019.1623785
Popat RA et al (2011) Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease. Eur J Neurol 18:756–765. https://doi.org/10.1111/j.1468-1331.2011.03353.x
Rayaprolu S et al (2013) TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease. Mol Neurodegener 8:19. https://doi.org/10.1186/1750-1326-8-19
Ruszkiewicz JA, Tinkov AA, Skalny AV, Siokas V, Dardiotis E, Tsatsakis A, Bowman AB, da Rocha JBT, Aschner M (2019) Brain diseases in changing climate. Environ Res 177:108637. https://doi.org/10.1016/j.envres.2019.108637
Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445–449
Sardiello M, Annunziata I, Roma G, Ballabio A (2005) Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum Mol Genet 14:3203–3217. https://doi.org/10.1093/hmg/ddi351
Sharma N (2019) Neuropathology of dystonia. Tremor Other Hyperkinet Mov (N Y) 9:569. https://doi.org/10.7916/d8-j6sx-b156
Shetty AS, Bhatia KP, Lang AE (2019) Dystonia and Parkinson’s disease: what is the relationship? Neurobiol Dis 132:104462. https://doi.org/10.1016/j.nbd.2019.05.001
Siokas V et al (2017a) Plasminogen activator inhibitor type-1 tag single-nucleotide polymorphisms in patients with diabetes mellitus type 2 and diabetic retinopathy. Curr Eye Res 42:1048–1053. https://doi.org/10.1080/02713683.2016.1276197
Siokas V et al (2017b) The role of TOR1A polymorphisms in dystonia: a systematic review and meta-analysis. PLoS One 12:e0169934. https://doi.org/10.1371/journal.pone.0169934
Siokas V et al (2017c) SLC2A1 tag SNPs in Greek patients with diabetic retinopathy and nephropathy. Ophthalmic Res. https://doi.org/10.1159/000480241
Siokas V, Aloizou AM, Tsouris Z, Michalopoulou A, Mentis AA, Dardiotis E (2018) Risk factor genes in patients with dystonia: a comprehensive review. Tremor Other Hyperkinet Mov (N Y) 8:559. https://doi.org/10.7916/d8h438gs
Siokas V et al (2019a) BDNF rs6265 (Val66Met) polymorphism as a risk factor for blepharospasm. Neuromolecular Med 21:68–74. https://doi.org/10.1007/s12017-018-8519-5
Siokas V et al (2019b) Lack of association of the rs11655081 ARSG gene with blepharospasm. J Mol Neurosci 67:472–476. https://doi.org/10.1007/s12031-018-1255-3
Siokas V, Aslanidou P, Aloizou AM, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E (2020) Does the CD33 rs3865444 polymorphism confer susceptibility to Alzheimer’s disease? J Mol Neurosci. https://doi.org/10.1007/s12031-020-01507-w
Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209–213. https://doi.org/10.1038/ng1706
Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929. https://doi.org/10.1093/bioinformatics/btl268
Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T (2012) The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 27:1789–1796. https://doi.org/10.1002/mds.25244
Tian J et al (2018) Whole-exome sequencing for variant discovery in blepharospasm. Mol Genet Genomic Med. https://doi.org/10.1002/mgg3.411
Tsatsakis AM et al (2017) Simulating real-life exposures to uncover possible risks to human health: a proposed consensus for a novel methodological approach. Hum Exp Toxicol 36:554–564. https://doi.org/10.1177/0960327116681652
Tsatsakis AM et al (2018) The dose response principle from philosophy to modern toxicology: the impact of ancient philosophy and medicine in modern toxicology science. Toxicol Rep 5:1107–1113. https://doi.org/10.1016/j.toxrep.2018.10.001
Tsatsakis AM et al (2019) Hormetic neurobehavioral effects of low dose toxic chemical mixtures in real-life risk simulation (RLRS) in rats. Food Chem Toxicol 125:141–149. https://doi.org/10.1016/j.fct.2018.12.043
Valls-Sole J, Defazio G (2016) Blepharospasm: update on epidemiology, clinical aspects, and pathophysiology. Front Neurol 7:45. https://doi.org/10.3389/fneur.2016.00045
Yoshihara T et al (2019) Influence of genetic polymorphisms and habitual caffeine intake on the changes in blood pressure, pulse rate, and calculation speed after caffeine intake: a prospective, double blind, randomized trial in healthy volunteers. J Pharmacol Sci 139:209–214. https://doi.org/10.1016/j.jphs.2019.01.006
Funding
This study was supported in part by a research grant from the Research Committee of the University of Thessaly, Greece (code 5287).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This research study was approved by the Local Ethics Committee and was performed according to the Declaration of Helsinki.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Siokas, V., Kardaras, D., Aloizou, AM. et al. CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm. J Mol Neurosci 70, 1370–1375 (2020). https://doi.org/10.1007/s12031-020-01553-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01553-4